08 April 2020
The current pandemic is a stress test for our health care systems and sky-high medicines prices are one of the problems that need solving. As vaccines, testing kits and treatments are urgently needed to tackle COVID-19, BEUC urges the EU to ensure that public funding into treatment research results in medicines that are affordable to all. Experience shows that public investment in medicines research − such as cancer drugs − does not always ensure fair prices.
13 March 2020
The COVID-19 outbreak has resulted in major disruption to people’s daily lives, travels and finances. Consumer groups from the BEUC network are advising people in their countries what to do. Please find below a list of advice for your country, in addition to the recommendations of the World Health Organization (WHO) and your governments.
17 December 2019
The top priorities for action by the new European Commission to advance the interests of Europe’s consumers during its five-year mandate have been outlined by The European Consumer Organisation (BEUC) in mission letters sent to nine members of the new Commission team.
Our work areas
As consumers are faced with a growing amount of information from different sources, we advocate for high quality and non-promotional information about health products.
The ageing of the population, rising healthcare costs and the economic crisis are challenging the sustainability of healthcare systems and consumers’ access to treatments.
Health scandals such as the weight-loss drug Mediator and the faulty PIP breast implants keep undermining consumers’ confidence in the safety of available health products and their oversight by the competent authorities.
- Ensure consumers have access to high quality healthcare in all EU Member States
- Guarantee consumers benefit from safe and innovative treatments
- Allow consumers to make informed choices regarding their health